AbbVie at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

AbbVie brings 3 presentations to SfN 2026 in Washington. Its presentations centre on how tau and alpha-synuclein pathology spreads in mouse models of neurodegenerative disease. One thread examines whether anti-tau antibodies can reduce tau propagation.

OrganizationSfN 2026 Attendance
AbbVie
Cambridge, MA
abbvie.com
Drug developers
Pharmaceutical company conducting neuroscience research, including work in movement disorders.
Poster
Sat Nov 14
1–5pm
Poster
Sun Nov 15
1–5pm
Poster
Mon Nov 16
1–5pm

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from AbbVie

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction